The newly proposed Metabolic Score for Visceral Fat is a reliable tool for identifying non-alcoholic fatty liver disease, requiring attention to age-specific effects in both sexes

Abstract

ObjectiveThe newly proposed Metabolic Visceral Fat Score (METS-VF) is considered a more effective measure for visceral adipose tissue (VAT) than other obesity indicators. This study aimed to reveal the association between METS-VF and non-alcoholic fatty liver disease (NAFLD), and its variations across age groups within both sexes.MethodsData from 14,251 medical examiners in the NAGALA project were employed in this study. 3D fitted surface plots were constructed based on multivariate logistic regression models to visualize the isolated and combined effects of aging and METS-VF on NAFLD. Receiver operating characteristic curve (ROC) analysis was conducted to compare the diagnostic performance of METS-VF with other VAT surrogate markers in predicting NAFLD.ResultsThe results of multivariate logistic regression analysis showed that each unit increase in METS-VF was independently associated with a 333% and 312% increase in the odds of NAFLD in males and females, respectively. Additionally, the 3D fitted surface plot showed that age significantly influenced the association between METS-VF and the odds of NAFLD in both sexes, as follows: (i) In males, when METS-VF was less than 6.2, the METS-VF-related odds of NAFLD increased gradually with age in the 20-45 age group, reached a plateau in the 45-65 age group, and then decreased in the group above 65 years old; however, when male METS-VF exceeded 6.2, aging and METS-VF combined to further increase the odds of NAFLD in all age groups, particularly in the 45-65 age group. (ii) In females, aging seemed to reduce METS-VF-related odds of NAFLD in the 18-40 age group, but significantly increased it in the 40-60 age group, particularly for those with higher METS-VF levels. Further ROC analysis revealed that compared to other VAT surrogate markers, METS-VF showed the highest diagnostic accuracy for NAFLD in females, especially in those under 45 years of age [area under the curve (AUC) = 0.9256].ConclusionsThis study firstly revealed a significant positive correlation between METS-VF and the odds of NAFLD, with METS-VF surpassing other VAT surrogate markers in NAFLD diagnosis. Moreover, age significantly influenced the METS-VF-related odds of NAFLD and METS-VF’s diagnostic efficacy for NAFLD in both sexes.

Association between indicators of visceral lipid accumulation and infertility: a cross-sectional study based on U.S. women

“…Metabolic syndrome is not only linked to female fertility but also to the onset of various other diseases [ 59 ]. While the other indicators, such as BMI, WC, and VAI only provide a rough estimate of visceral adipose tissue content based on the distribution of body fat and do not precise depictions of the impact of fat on metabolism, the METS-VF effectively captures the influence of visceral adipose tissue on metabolism [ 60 ]. In summary, the current work has demonstrated that METS-VF is a reliable indicator of both female infertility and visceral obesity.…”

Association between metabolic score of visceral fat and carotid atherosclerosis in Chinese health screening population: a cross-sectional study

“…METS-VF is closely associated with metabolic diseases, and is a reliable predictor for the development of type 2 diabetes (AUC: 0.690, 95% CI: 0.682–0.698), metabolic syndrome (AUC: 0.952, 95% CI: 0.951–0.953), non-alcoholic fatty liver disease (NAFLD) (AUC: 0.812, 95% CI: 0.802–0.823), and chronic kidney disease (AUC: 0.634, 95% CI: 0.589–0.680) [ 10 – 13 ]. Moreover, METS-VF exhibits a robust association with several diseases, including kidney stones, asthma, hypertension, and hyperuricaemia [ 14 – 17 ].…”